Jon Andoni Barrueta

Suggest Changes
Learn More
The current healthcare climate demands pharmacoeconomic evaluations for different treatment strategies incorporating drug acquisition costs, costs incurred for hospitalisation, drug administration(More)
Objectives: To find out the average direct hospitalization cost and length of hospital stay for patients infected with Carbapenem-resistant Klebsiella pneumonia (CRKp) and compare it with that of(More)
OBJECTIVE According to a recent randomized, double-blind clinical trial comparing the combination of voriconazole and anidulafungin (VOR+ANI) with VOR monotherapy for invasive aspergillosis (IA) in(More)
• A decision tree model was performed (Figure 1). • The success (clinical and microbiological response) and safety (hepatic and renal adverse effects) of first-line treatments were obtained from(More)
  • 1